Case Study: Becton Dickinson combats hospital drug diversion with Microsoft Corporation's AI-powered analytics

Becton Dickinson uses data science to help customers identify potential drug diversion

Becton Dickinson, a global medical technology company, faced the growing challenge of hospital drug diversion amid the U.S. opioid crisis. Traditional manual and segmented reporting methods made it difficult for healthcare organizations to detect suspicious medication behavior quickly and accurately.

Microsoft Corporation partnered with Becton Dickinson to build the BD HealthSight™ Diversion Management analytics application using Azure and AI/machine learning. The solution analyzes more than 50 signals to flag anomalies, assign risk scores, and streamline investigations, helping hospitals identify potential diversion earlier and reduce false positives while improving medication management and lowering downtime and operational costs.

Becton Dickinson

Tom Utech

VP, Solution Management and Marketing , Medication Management Solutions